Neuroacanthocytosis Syndromes

Neuroacanthocytosis Syndromes: What Links Red Blood Cells and Neurons?....Pages 1-14
The Differential Diagnosis of Neuroacanthocytosis: An Overview....Pages 15-20
Acanthocytes and Disorders of Lipoprotein Metabolism....Pages 21-30
Levine-Critchley Syndrome of Neuroacanthocytosis: A Clinical Review....Pages 31-37
Chorea-Acanthocytosis with the Ehime-Deletion Mutation....Pages 39-43
McLeod Syndrome: A Clinical Review....Pages 45-53
Autosomal-Dominant Chorea-Acanthocytosis: Report of a Family and Neuropathology....Pages 55-65
Acanthocytes in Pantothenate Kinase Associated Neurodegeneration....Pages 67-70
Diagnostic Test for Neuroacanthocytosis: Quantitative Measurement of Red Blood Cell Morphology....Pages 71-77
Differential Diagnosis of Serum Creatine Kinase Elevation....Pages 79-86
Pathology of Neuroacanthocytosis and of Huntington’s Disease....Pages 87-94
Cognitive and Neuropsychiatric Findings in McLeod Syndrome and in Chorea-Acanthocytosis....Pages 95-115
Epilepsy in Neuroacanthocytosis....Pages 117-122
Sleep Features in Chorea-Acanthocytosis....Pages 123-125
Neuromuscular Findings in Eight Italian Families with Neuroacanthocytosis....Pages 127-138
Cardiac Involvement in the Neuroacanthocytosis Syndromes....Pages 139-152
Erythrocyte Membrane Abnormalities in Neuroacanthocytosis: Evidence for a Neuron-Erythrocyte Axis?....Pages 153-159
Erythrocyte Membrane Anion Exchange Abnormalities in Chorea-Acanthocytosis: the Band 3 Network....Pages 161-167
The Spectrum of Mutations and Possible Function of the CHAC Gene....Pages 169-175
Immunohematology of the Kell and KX Blood Group Systems....Pages 177-186
C. Elegans as a Disease Model for Neuroacanthocytosis....Pages 187-195
The Kell Blood Group Protein, its Relation to XK and its Function as an Endothelin-3-Converting Enzyme....Pages 197-203
Endothelins as Basal Ganglia Transmitters....Pages 205-212
Substrates for Transglutaminase-Catalyzed Cross-Linking: Relevance to Pathogenesis of Huntington’s Disease and Chorea-Acanthocytosis....Pages 213-221
Huntington’s Disease Animal Models: What Lessons Can Be Learned for Research on Neuroacanthocytosis Syndromes?....Pages 223-231
Motor Deficits as Biomarkers in Huntington’s Disease: Perspectives for Neuroacanthocytosis Syndromes....Pages 233-242
Treatment Options in Huntington’s Disease....Pages 243-250
Is Surgical Treatment an Option for Chorea-Acanthocytosis?....Pages 251-257
The Potential for Gene Therapy of Neurodegenerative Disorders....Pages 259-267
Research Agenda in Neuroacanthocytosis....Pages 269-275